Maloney, M. E., Springhart, W. P., Marguet, C. G., L’Esperance, J. O., Albala, D. M., & Preminger, G. M. (2004). 1146: Appropriate Medical Treatment After Percutaneous Nephrolithotomy can Control Active Stone Disease in the Presence of Residual Calculi. In Journal of Urology (Vol. 171, pp. 302–302). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/s0022-5347(18)38383-6

Maloney, Michaella E., W Patrick Springhart, Charles G. Marguet, James O. L’Esperance, David M. Albala, and Glenn M. Preminger. “1146: Appropriate Medical Treatment After Percutaneous Nephrolithotomy can Control Active Stone Disease in the Presence of Residual Calculi.” In Journal of Urology, 171:302–302. Ovid Technologies (Wolters Kluwer Health), 2004. https://doi.org/10.1016/s0022-5347(18)38383-6.

Maloney ME, Springhart WP, Marguet CG, L’Esperance JO, Albala DM, Preminger GM. 1146: Appropriate Medical Treatment After Percutaneous Nephrolithotomy can Control Active Stone Disease in the Presence of Residual Calculi. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2004. p. 302–302.

Maloney, Michaella E., et al. “1146: Appropriate Medical Treatment After Percutaneous Nephrolithotomy can Control Active Stone Disease in the Presence of Residual Calculi.” Journal of Urology, vol. 171, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2004, pp. 302–302. Crossref, doi:10.1016/s0022-5347(18)38383-6.

Maloney ME, Springhart WP, Marguet CG, L’Esperance JO, Albala DM, Preminger GM. 1146: Appropriate Medical Treatment After Percutaneous Nephrolithotomy can Control Active Stone Disease in the Presence of Residual Calculi. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2004. p. 302–302.